Cited by 813Nosocomial Infections in ICUSepsis Diagnosis and TreatmentAntifungal resistance and susceptibility

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Decontamination of the Digestive Tract and Oropharynx in ICU Patients

Open access

Abstract

BACKGROUND: Selective digestive tract decontamination (SDD) and selective oropharyngeal decontamination (SOD) are infection-prevention measures used in the treatment of some patients in intensive care, but reported effects on patient outcome are conflicting. METHODS: We evaluated the effectiveness of SDD and SOD in a crossover study using cluster randomization in 13 intensive care units (ICUs), all in The Netherlands. Patients with an expected duration of intubation of more than 48 hours or an expected ICU stay of more than 72 hours were eligible. In each ICU, three regimens (SDD, SOD, and standard care) were applied in random order over the course of 6 months. Mortality at day 28 was the primary end point. SDD consisted of 4 days of intravenous cefotaxime and topical application of tobramycin, colistin, and amphotericin B in the oropharynx and stomach. SOD consisted of oropharyngeal application only of the same antibiotics. Monthly point-prevalence studies were performed to analyze antibiotic resistance. RESULTS: A total of 5939 patients were enrolled in the study, with 1990 assigned to standard care, 1904 to SOD, and 2045 to SDD; crude mortality in the groups at day 28 was 27.5%, 26.6%, and 26.9%, respectively. In a random-effects logistic-regression model with age, sex, Acute Physiology and Chronic Health Evaluation (APACHE II) score, intubation status, and medical specialty used as covariates, odds ratios for death at day 28 in the SOD and SDD groups, as compared with the standard-care group, were 0.86 (95% confidence interval [CI], 0.74 to 0.99) and 0.83 (95% CI, 0.72 to 0.97), respectively. CONCLUSIONS: In an ICU population in which the mortality rate associated with standard care was 27.5% at day 28, the rate was reduced by an estimated 3.5 percentage points with SDD and by 2.9 percentage points with SOD. (Controlled Clinical Trials number, ISRCTN35176830.)

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa0800394

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 34 references

Cited by

Sorted by citations

Items 501–600 of 806

Metadata

Authors
de Smet, A. M. G. A., Kluytmans, J. A. J. W., Cooper, B. S., Mascini, E. M., Benus, R. F. J., van der Werf, T. S., van der Hoeven, J. G., Pickkers, P., Bogaers-Hofman, D., van der Meer, N. J. M., Bernards, A. T., Kuijper, E. J., Joore, J. C. A., Leverstein-van Hall, M. A., Bindels, A. J. G. H., Jansz, A. R., Wesselink, R. M. J., de Jongh, B. M., Dennesen, P. J. W., van Asselt, G. J., te Velde, L. F., Frenay, I. H. M. E., Kaasjager, K., Bosch, F. H., van Iterson, M., Thijsen, S. F. T., Kluge, G. H., Pauw, W., de Vries, J. W., Kaan, J. A., Arends, J. P., Aarts, L. P. H. J., Sturm, P. D. J., Harinck, H. I. J., Voss, A., Uijtendaal, E. V., Blok, H. E. M., Thieme Groen, E. S., Pouw, M. E., Kalkman, C. J., & Bonten, M. J. M.
Affiliations
  • University Medical Center Utrecht (NL)
  • Amphia Ziekenhuis (NL)
  • Rijnstate Hospital (NL)
  • Utrecht University (NL)
  • Leiden University Medical Center (NL)
  • Diakonessenhuis hospital (NL)
  • Catharina Ziekenhuis (NL)
Venue
New England Journal of Medicine
Published
2009-01
Volume
360
Issue
1
Pages
20-31
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2065088137
Cited by
813
References
34
Citations by year
2026: 12 · 2025: 22 · 2024: 16 · 2023: 30 · 2022: 32 · 2021: 39 · 2020: 36 · 2019: 29 · 2018: 39 · 2017: 48 · 2016: 45 · 2015: 61 · 2014: 52 · 2013: 62 · 2012: 68
FWCI
59.40
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
  • Radboud Repository (Radboud University) (submittedVersion, other-oa)
  • Pure Amsterdam UMC (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Topics
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Keywords
selective decontamination of the digestive tract, selective oropharyngeal decontamination, intensive care unit patients, nosocomial infection prevention, 28-day mortality, cefotaxime, tobramycin, colistin, amphotericin B, antibiotic resistance, intubation, critically ill patients
MeSH terms
Aged, Anti-Bacterial Agents, Cross Infection, Decontamination, Female, Gram-Negative Bacteria, Humans, Intensive Care Units, Male, Middle Aged, Oropharynx, Respiration, Artificial, Logistic Models, Bacteremia, Critical Illness, Infection Control, Cross-Over Studies, APACHE, Gastrointestinal Tract

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review